Thirty-day morbidity and mortality of bariatric and metabolic surgery in patients with type 2 diabetes mellitus: A subset analysis of the GENEVA cohort study
Rishi Singhal1, Victor Roth Cardoso2, Christian Ludwig3, Jonathan Super4, Yashasvi Rajeev5, Gavin Rudge6, Georgios V Gkoutos7, Kamal Mahawar8, GENEVA collaborators9
1 Department of General Surgery, Upper GI Unit, University Hospital Birmingham NHS Foundation Trust, West Midlands, United Kingdom 2 Institute of Cancer and Genomic Sciences, University of Birmingham, West Midlands; Health Data Research UK Midlands, Birmingham, United Kingdom 3 Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom 4 Department of General Surgery, Maidstone and Tunbridge Wells NHS Trust, Royal Tunbridge Wells, Harrow, London, United Kingdom 5 Department of Surgery, London Northwest University Healthcare NHS Trust, Harrow, London, United Kingdom 6 Institute of Applied Health Research, Murray Learning Centre, University of Birmingham, Birmingham, United Kingdom 7 Institute of Cancer and Genomic Sciences, University of Birmingham, West Midlands; Health Data Research UK Midlands; NIHR Biomedical Research Centre; NIHR Surgical Reconstruction and Microbiology Research Centre, Birmingham, United Kingdom 8 Department of General Surgery, Bariatric Unit, South Tyneside and Sunderland NHS Trust, Sunderland, United Kingdom
Correspondence Address:
Rishi Singhal Department of General Surgery, Upper GI Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham United Kingdom
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jbs.jbs_1_21
|